Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

Published:2024-08 Issue: Volume:76 Page:103753
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Schettini Francesco^ORCID,Saracchini Silvana,Bassini Anna,Marus Wally,Corsetti Serena,Specogna Ilaria,Bertola Manuela,Micheli Elvia,Wirtz Ralph M.,Laible Mark,Şahin Uğur,Strina Carla,Milani Manuela,Aguggini Sergio,Tancredi Richard,Fiorio Elena,Sulfaro Sandro,Generali Daniele^ORCID

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Reference51 articles.

1. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

2. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients;Yau;Lancet Oncol,2022

3. Trastuzumab Emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;N Engl J Med,2019

4. Adjuvant Capecitabine for breast cancer after preoperative chemotherapy;Masuda;N Engl J Med,2017

5. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer;Tutt;N Engl J Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP